When does HeartBeam report earnings and how will it affect BEAT stock?

HeartBeam reports on **2026-03-12** after market close. Earnings and guidance could move BEAT stock sharply because trading volume is elevated and fundamentals are tight, increasing sensitivity to revenue or cash-flow guidance.

What is Meyka AI's forecast for BEAT stock and the implied upside?

Meyka AI's forecast projects **2.13 USD** in 12 months for BEAT stock, implying an upside of **~42.63%** from the current **1.35 USD**. Forecasts are model-based and not guarantees.

What are the main risks investors should watch in BEAT stock?

Primary risks include negative EPS **-0.66**, tight liquidity with cash per share **0.05**, potential delisting attention, and a high price-to-book ratio. Execution on commercialization and AI partnerships is critical.

Are there near-term catalysts that could change the BEAT stock outlook?

Yes. The March 12 earnings report, Oppenheimer and ROTH presentations, and demos at ACC.26 are near-term catalysts. Positive evidence on adoption or reimbursement could lift BEAT stock.

US Stocks

After Hours: HeartBeam (BEAT) NASDAQ $1.35 (-8.78%) pre-Mar 12 earnings: watch guidance

ByDanny Kontos March 11, 2026March 11, 2026

BEAT stock opened a sharp after-hours focus at $1.35, down -8.78%, as investors position ahead of HeartBeam, Inc.’s (BEAT) March 12, 2026 earnings release. Trading volume surged to 32,574,883 shares today, far above the 7,000,000 average, signaling heightened liquidity risk and interest. We set out the key metrics, analyst signals, and what to watch in the NASDAQ-listed HeartBeam (United States, USD) report that could reshape the short-term outlook.